Nephrotic Syndrome Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Clinical Trials
• Forums

Phase III Study of Rituximab (Genetical Recombination) for the Treatment for Idiopathic Membranous Nephropathy With Nephrotic Syndrome
Conditions:   Glomerulonephritis, Membranous;   Nephrotic Syndrome，Idiopathic Interventions:   Drug: Rituximab (genetical recombination);   Drug: Placebo Sponsor:   Shoichi Maruyama MD PhD Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials

Renal Doppler in Pediatric Patients With Idiopathic Nephrotic Syndrome
Condition:   Nephrotic Syndrome Intervention:   Device: renal doppler Sponsor:   Tanta University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials

Phase III Study of Rituximab (Genetical Recombination) for the Treatment for Idiopathic Membranous Nephropathy With Nephrotic Syndrome
Conditions:   Glomerulonephritis, Membranous;   Nephrotic Syndrome，Idiopathic Interventions:   Drug: Rituximab (genetical recombination);   Drug: Placebo Sponsor:   Shoichi Maruyama MD PhD Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials

Renal Doppler in Pediatric Patients With Idiopathic Nephrotic Syndrome
Condition:   Nephrotic Syndrome Intervention:   Device: renal doppler Sponsor:   Tanta University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials

Phase III Study of Rituximab (Genetical Recombination) for the Treatment for Idiopathic Membranous Nephropathy With Nephrotic Syndrome
Conditions:   Glomerulonephritis, Membranous;   Nephrotic Syndrome，Idiopathic Interventions:   Drug: Rituximab (genetical recombination);   Drug: Placebo Sponsor:   Shoichi Maruyama MD PhD Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials

Effectiveness of Educational Gamified Cards About Nephrotic Syndrome
Condition:   Nephrotic Syndrome Intervention:   Other: Gamified Cards about Nephrotic Syndrome Sponsor:   Mansoura University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 15, 2023 Category: Research Source Type: clinical trials